Literature DB >> 31762856

Opportunities for pharmacists in vaccinating higher-risk populations.

Carolyn Whiskin1,2, Nora Cutcliffe1,2.   

Abstract

Year:  2019        PMID： 31762856      PMCID： PMC6851639          DOI： 10.1177/1715163519877898

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  16 in total

Review 1.  Immunosenescence: Influenza vaccination and the elderly.

Authors:  Kamran Haq; Janet E McElhaney
Journal:  Curr Opin Immunol       Date:  2014-04-25       Impact factor: 7.486

2.  Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

Authors:  Jeffrey C Kwong; Kevin L Schwartz; Michael A Campitelli; Hannah Chung; Natasha S Crowcroft; Timothy Karnauchow; Kevin Katz; Dennis T Ko; Allison J McGeer; Dayre McNally; David C Richardson; Laura C Rosella; Andrew Simor; Marek Smieja; George Zahariadis; Jonathan B Gubbay
Journal:  N Engl J Med       Date:  2018-01-25       Impact factor: 91.245

Review 3.  Vaccination of special populations: Protecting the vulnerable.

Authors:  Mark Doherty; Ruprecht Schmidt-Ott; Jose Ignacio Santos; Lawrence R Stanberry; Annika M Hofstetter; Susan L Rosenthal; Anthony L Cunningham
Journal:  Vaccine       Date:  2016-11-18       Impact factor: 3.641

4.  Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations.

Authors:  Nadira Husein; Ashen Chetty
Journal:  Can J Diabetes       Date:  2018-04       Impact factor: 4.190

5.  Statement on the Use of Conjugate Pneumococcal Vaccine - 13 Valent in Adults (Pneu-C-13): An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  C Quach-Thanh; Ms H Thomas
Journal:  Can Commun Dis Rep       Date:  2013-10-30

Review 6.  Fluzone® High-Dose Influenza Vaccine.

Authors:  Corwin A Robertson; Carlos A DiazGranados; Michael D Decker; Ayman Chit; Monica Mercer; David P Greenberg
Journal:  Expert Rev Vaccines       Date:  2016-11-14       Impact factor: 5.217

7.  Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary.

Authors:  Kim A Papp; Boulos Haraoui; Deepali Kumar; John K Marshall; Robert Bissonnette; Alain Bitton; Brian Bressler; Melinda Gooderham; Vincent Ho; Shahin Jamal; Janet E Pope; A Hillary Steinhart; Donald C Vinh; John Wade
Journal:  J Rheumatol       Date:  2019-02-01       Impact factor: 4.666

8.  Rates of pneumococcal disease in adults with chronic medical conditions.

Authors:  Kimberly M Shea; John Edelsberg; Derek Weycker; Raymond A Farkouh; David R Strutton; Stephen I Pelton
Journal:  Open Forum Infect Dis       Date:  2014-05-27       Impact factor: 3.835

9.  Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.

Authors:  Jin Kyun Park; Yun Jong Lee; Kichul Shin; You-Jung Ha; Eun Young Lee; Yeong Wook Song; Yunhee Choi; Kevin L Winthrop; Eun Bong Lee
Journal:  Ann Rheum Dis       Date:  2018-03-23       Impact factor: 19.103

10.  Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012.

Authors:  Emad A Yanni; Germano Ferreira; Morgane Guennec; Yassine El Hahi; Amale El Ghachi; François Haguinet; Emmanuelle Espie; Veronique Bianco
Journal:  BMJ Open       Date:  2018-06-07       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.